載入...
Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
Hepatitis C virus (HCV) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) in the US and Japan. Therefore, eradication of HCV may reduce the occurrence of HCC in HCV-infected individuals. In 2011, the use of first-generation HCV NS3/4A protease inhibitors such as telaprevir and bocep...
Na minha lista:
| 發表在: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
XIA & HE Publishing Ltd
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521257/ https://ncbi.nlm.nih.gov/pubmed/26356295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2013.00025 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|